Evidence map›Paper›PMID 38510715›Full record

ArticleJACC. Basic to translational science2024

Evidence That Anemia Accelerates AS Progression Via Shear-Induced TGF-β1 Activation: Heyde's Syndrome Comes Full Circle.

Kumar Subramani, Jeffrey Bander, Sixia Chen, Mayte Suárez-Fariñas, Thamizhiniyan Venkatesan, Sandeep Subrahmanian, Rohan Varshney, Annapoorna Kini, Samin Sharma, Daniel B Rifkin and 3 more

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 1 country.

Kumar SubramaniCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Jeffrey BanderIcahn School of Medicine at Mount Sinai New York, New York, USA.
Sixia ChenUniversity of Oklahoma Health Sciences Centers, Oklahoma City, Oklahoma, USA.
Mayte Suárez-FariñasIcahn School of Medicine at Mount Sinai New York, New York, USA.
Thamizhiniyan VenkatesanCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Sandeep SubrahmanianCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Rohan VarshneyCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Annapoorna KiniIcahn School of Medicine at Mount Sinai New York, New York, USA.
Samin SharmaIcahn School of Medicine at Mount Sinai New York, New York, USA.
Daniel B RifkinDepartments of Cell Biology and Medicine, New York University, New York, New York, USA.
Jaehyung ChoWashington University School of Medicine, St. Louis, Missouri, USA.
Barry S CollerLaboratory of Blood and Vascular Biology, Rockefeller University, New York, New York, USA.
Jasimuddin AhamedCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Oklahoma Medical Research Foundation · USIcahn School of Medicine at Mount Sinai · USNew York University · USRockefeller University · USUniversity of Oklahoma Health Sciences Center · USWashington University in St. Louis · US

Funding

Platelet Integrin AlphaIIbBeta3 Structure, Activation, and Ligand Binding: Fibrinogen, Fibrin, D-dimer, and von Willebrand FactorR01HL019278 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI Claudia Lorena Buitrago, Barry Coller · 1985 to 2026
$17.6M
The Role of TGF-beta Activation and Signaling in Aortic Stenosis ProgressionR01HL148123 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Jasimuddin Ahamed · 2020 to 2026
$2.9M
Cardiovascular Risk of Antiretroviral Therapy Drugs in HIVR01HL167656 · NHLBI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI Jasimuddin Ahamed · 2023 to 2026
$2.7M
Ero1α in platelet activity and thrombosisR01HL146559 · NHLBI · WASHINGTON UNIVERSITY · PI CHO, JAEHYUNG · 2020 to 2023
$1.7M
Role of intravascular ERO1@ in acute lung injuryR01HL153047 · NHLBI · WASHINGTON UNIVERSITY · PI CHO, JAEHYUNG · 2020 to 2023
$1.6M
NHLBI NIH HHS R01 HL019278NHLBI NIH HHS R01 HL146559NHLBI NIH HHS R01 HL148123NHLBI NIH HHS R01 HL153047NHLBI NIH HHS R01 HL167656
6 · The paper itself

Abstract

The severity of aortic stenosis (AS) is associated with acquired von Willebrand syndrome (AVWS) and gastrointestinal bleeding, leading to anemia (Heyde's syndrome). We investigated how anemia is linked with AS and AVWS using the LA100 mouse model and patients with AS. Induction of anemia in LA100 mice increased transforming growth factor (TGF)-β1 activation, AVWS, and AS progression. Patients age >75 years with severe AS had higher plasma TGF-β1 levels and more severe anemia than AS patients age <75 years, and there was a correlation between TGF-β1 and anemia. These data are compatible with the hypothesis that the blood loss anemia of Heyde's syndrome contributes to AS progression via WSS-induced activation of platelet TGF-β1 and additional gastrointestinal bleeding via WSS-induced AVWS.

Indexed as

anemiaaortic stenosisAVWSGI bleedingHeyde’s syndromeTGF-beta

Identifiers

PMID38510715
PMCPMC10950403
OpenAlexW4388125648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.